P. Jeannet, G. Bassez, and B. Eymard, Clinical and histologic findings in autosomal centronuclear myopathy, Neurology, vol.62, issue.9, pp.1484-1490, 2004.
DOI : 10.1212/01.WNL.0000124388.67003.56

H. Jungbluth, C. Wallgren-pettersson, and J. Laporte, Centronuclear (myotubular) myopathy, Orphanet Journal of Rare Diseases, vol.3, issue.1, p.26, 2008.
DOI : 10.1186/1750-1172-3-26
URL : https://hal.archives-ouvertes.fr/inserm-00350775

C. Wallgren-pettersson, A. Clarke, F. Samson, M. Fardeau, V. Dubowitz et al., The myotubular myopathies: differential diagnosis of the X linked recessive, autosomal dominant, and autosomal recessive forms and present state of DNA studies., Journal of Medical Genetics, vol.32, issue.9, pp.673-682, 1995.
DOI : 10.1136/jmg.32.9.673

C. Pierson, K. Tomczak, P. Agrawal, B. Moghadaszadeh, and A. Beggs, X-Linked Myotubular and Centronuclear Myopathies, Journal of Neuropathology & Experimental Neurology, vol.64, issue.7, pp.555-64, 2005.
DOI : 10.1097/01.jnen.0000171653.17213.2e

J. Laporte, L. Hu, and C. Kretz, A gene mutated in X???linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast, Nature Genetics, vol.269, issue.2, pp.175-182, 1996.
DOI : 10.1146/annurev.physiol.53.1.201

J. Laporte, F. Bedez, and A. Bolino, Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases, Human Molecular Genetics, vol.12, issue.suppl 2, pp.285-92, 2003.
DOI : 10.1093/hmg/ddg273

J. Laporte, L. Liaubet, F. Blondeau, H. Tronchere, J. Mandel et al., Functional Redundancy in the Myotubularin Family, Biochemical and Biophysical Research Communications, vol.291, issue.2, pp.305-312, 2002.
DOI : 10.1006/bbrc.2002.6445

C. Cao, J. Laporte, J. Backer, A. Wandinger-ness, and M. Stein, Myotubularin Lipid Phosphatase Binds the hVPS15/hVPS34 Lipid Kinase Complex on Endosomes, Traffic, vol.55, issue.8, pp.1052-1067, 2007.
DOI : 10.1111/j.1600-0854.2007.00586.x
URL : https://hal.archives-ouvertes.fr/hal-00189162

M. Bitoun, S. Maugenre, and P. Jeannet, Mutations in dynamin 2 cause dominant centronuclear myopathy, Nature Genetics, vol.111, issue.11, pp.1207-1209, 2005.
DOI : 10.1083/jcb.100.1.35
URL : https://hal.archives-ouvertes.fr/hal-00187451

G. Praefcke and H. Mcmahon, The dynamin superfamily: universal membrane tubulation and fission molecules?, Nature Reviews Molecular Cell Biology, vol.5, issue.2, pp.133-180, 2004.
DOI : 10.1038/nrm1313

P. Guicheney, Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset, Ann Neurol, vol.62, pp.666-70, 2007.

A. Nicot, A. Toussaint, and V. Tosch, Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy, Nature Genetics, vol.18, issue.9, pp.1134-1139, 2007.
DOI : 10.1093/nar/16.1.369
URL : https://hal.archives-ouvertes.fr/hal-00189145

T. Itoh, D. Camilli, P. Bar, and F. , BAR, F-BAR (EFC) and ENTH/ANTH domains in the regulation of membrane???cytosol interfaces and membrane curvature, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1761, issue.8, pp.897-912, 2006.
DOI : 10.1016/j.bbalip.2006.06.015

E. Lee, M. Marcucci, and L. Daniell, Amphiphysin 2 (Bin1) and T-Tubule Biogenesis in Muscle, Science, vol.297, issue.5584, pp.1193-1199, 2002.
DOI : 10.1126/science.1071362

K. Claeys, T. Maisonobe, and J. Böhm, PHENOTYPE OF A PATIENT WITH RECESSIVE CENTRONUCLEAR MYOPATHY AND A NOVEL BIN1 MUTATION, Neurology, vol.74, issue.6, pp.519-521, 2010.
DOI : 10.1212/WNL.0b013e3181cef7f9

J. Schessl, L. Medne, and Y. Hu, MRI in DNM2-related centronuclear myopathy: Evidence for highly selective muscle involvement, Neuromuscular Disorders, vol.17, issue.1, pp.28-32, 2007.
DOI : 10.1016/j.nmd.2006.09.013

D. Fischer, M. Herasse, M. Bitoun, H. Barragán-campos, J. Chiras et al., Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy, Brain, vol.129, issue.6, pp.1463-1472, 2006.
DOI : 10.1093/brain/awl071

A. Mejaddam, I. Nennesmo, and T. Sejersen, Severe phenotype of a patient with autosomal recessive centronuclear myopathy due to a BIN1 mutation, Acta Myol, vol.XXVIII, pp.91-93, 2009.

D. Paolo, G. Sankaranarayanan, S. Wenk, and M. , Decreased Synaptic Vesicle Recycling Efficiency and Cognitive Deficits in Amphiphysin 1 Knockout Mice, Neuron, vol.33, issue.5, pp.789-804, 2002.
DOI : 10.1016/S0896-6273(02)00601-3

D. Sakamuro, K. Elliott, R. Wechsler-reya, and G. Prendergast, BIN1 is a novel MYC???interacting protein with features of a tumour suppressor, Nature Genetics, vol.4, issue.1, pp.69-77, 1996.
DOI : 10.1016/0378-1119(90)90317-K

A. Muller, J. Duhadaway, P. Donover, E. Sutanto-ward, and G. Prendergast, Targeted deletion of the suppressor gene bin1/amphiphysin2 accentuates the neoplastic character of transformed mouse fibroblasts, Cancer Biology & Therapy, vol.3, issue.12, pp.1236-1242, 2004.
DOI : 10.4161/cbt.3.12.1232

K. Ge, F. Minhas, J. Duhadaway, N. Mao, D. Wilson et al., Loss of heterozygosity and tumor suppressor activity ofBin1 in prostate carcinoma, International Journal of Cancer, vol.445, issue.2, pp.155-61, 2000.
DOI : 10.1002/(SICI)1097-0215(20000415)86:2<155::AID-IJC2>3.0.CO;2-M